Vivanza Biosciences: No Fundraising Deviation Statement

Vivanza Biosciences Limited has submitted a regulatory disclosure to BSE Limited confirming that a Statement of Deviation or Variation is not applicable to the company. This communication is made pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Circular No. CIR/CFD/CMD1/162/2019 dated 24th December, 2019.

The company confirms that it has not raised any further funds by means of Public Issue, Rights Issue, Preferential Issue, or Qualified Institutions Placement (QIP). As a result, no statement of deviation(s) or variation(s) from the proceeds of such issuances is required to be submitted.

The letter is signed by Jayendra Amichand Mehta, Managing Director (DIN: 08210602), and is addressed to the Department of Corporate Services at BSE Limited's office at Ground Floor, P. J. Towers, Dalal Street, Mumbai – 400 001.

Financial Impact

No financial impact disclosed. The filing is a regulatory compliance statement confirming the absence of fundraising activities that would require deviation reporting.